SCHEMBL5148461

SCHEMBL5148461

Nc1ncnn2c(CCn3cccc3)cc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c(F)c3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 6/20 0.51
RET P07949 3/20 0.51
FGFR1 P11362 3/20 0.51
FRK P42685 2/20 0.51
MAPK9 P45984 2/20 0.51
RPS6KA3 P51812 2/20 0.51
MAP4K2 Q12851 2/20 0.51
BCR P11274 1/20 0.51
PRKCD Q05655 1/20 0.51
DDR1 Q08345 1/20 0.51
TNK1 Q13470 1/20 0.51
RPS6KA1 Q15418 1/20 0.51
MAP3K11 Q16584 1/20 0.51
DDR2 Q16832 1/20 0.51
RPS6KA6 Q9UK32 1/20 0.51
TEK Q02763 6/20 0.46
FLT1 P17948 5/20 0.46
CSF1R P07333 4/20 0.46
FLT4 P35916 4/20 0.46
PDGFRB P09619 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57829 0.90 ACVRL1 (0.53) FLT3RETFGFR1FRKMAPK9
SCHEMBL59010 0.90 FLT3 (0.54) FLT3RETFGFR1FRKMAPK9
SCHEMBL59012 0.89 ACVRL1 (0.54) FLT3RETFGFR1FRKMAPK9
SCHEMBL59995 0.89 FLT3 (0.52) FLT3RETFGFR1FRKMAPK9
SCHEMBL60592 0.89 FLT3 (0.53) FLT3RETFGFR1FRKMAPK9
SCHEMBL60035 0.89 FLT3 (0.55) FLT3RETFGFR1FRKMAPK9
SCHEMBL59791 0.89 FLT3 (0.52) FLT3RETFGFR1FRKMAPK9
SCHEMBL59451 0.88 FGFR1 (0.53) FLT3RETFGFR1FRKMAPK9
SCHEMBL66065 0.87 FLT3 (0.56) FLT3RETFGFR1FRKMAPK9
SCHEMBL59726 0.87 FLT3 (0.54) FLT3RETFGFR1FRKMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP disclosed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO disclosed